DIN 02447886 — AURO-IRBESARTAN HCT 300 MG; 12.5 MG
AURO-IRBESARTAN HCT is a tablet of Irbesartan / Hydrochlorothiazide marketed by AURO PHARMA INC. The full Irbesartan / Hydrochlorothiazide monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02447886
- Brand name
- AURO-IRBESARTAN HCT
- Active ingredient
- Irbesartan / Hydrochlorothiazide
- Strength
- 300 MG; 12.5 MG
- Dosage form
- TABLET
- Route
- ORAL
- Manufacturer
- AURO PHARMA INC
- Health Canada status
- DORMANT
- Drug class
- Angiotensin II receptor blocker (ARB) and thiazide diuretic combination
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.
Other Irbesartan / Hydrochlorothiazide products
| DIN | Brand | Strength | Form | Manufacturer | Status |
|---|---|---|---|---|---|
| 02387646 | APO-IRBESARTAN/HCTZ | 150 MG; 12.5 MG | TABLET | APOTEX INC | DORMANT |
| 02387654 | APO-IRBESARTAN/HCTZ | 300 MG; 12.5 MG | TABLET | APOTEX INC | DORMANT |
| 02387662 | APO-IRBESARTAN/HCTZ | 300 MG; 25 MG | TABLET | APOTEX INC | DORMANT |
| 02447878 | AURO-IRBESARTAN HCT | 150 MG; 12.5 MG | TABLET | AURO PHARMA INC | DORMANT |
| 02447894 | AURO-IRBESARTAN HCT | 25 MG; 300 MG | TABLET | AURO PHARMA INC | DORMANT |
| 02241818 | AVALIDE | 12.5 MG; 150 MG | TABLET | SANOFI-AVENTIS CANADA INC | MARKETED |
| 02241819 | AVALIDE | 300 MG; 12.5 MG | TABLET | SANOFI-AVENTIS CANADA INC | MARKETED |
| 02385317 | IRBESARTAN HCT | 12.5 MG; 150 MG | TABLET | SIVEM PHARMACEUTICALS ULC | MARKETED |
| 02385325 | IRBESARTAN HCT | 12.5 MG; 300 MG | TABLET | SIVEM PHARMACEUTICALS ULC | MARKETED |
| 02385333 | IRBESARTAN HCT | 25 MG; 300 MG | TABLET | SIVEM PHARMACEUTICALS ULC | MARKETED |
| 02372886 | IRBESARTAN/HCTZ | 12.5 MG; 150 MG | TABLET | SANIS HEALTH INC | DORMANT |
| 02372894 | IRBESARTAN/HCTZ | 12.5 MG; 300 MG | TABLET | SANIS HEALTH INC | DORMANT |
| 02372908 | IRBESARTAN/HCTZ | 300 MG; 25 MG | TABLET | SANIS HEALTH INC | DORMANT |
| 02328518 | PMS-IRBESARTAN-HCTZ | 150 MG; 12.5 MG | TABLET | PHARMASCIENCE INC | MARKETED |
| 02328526 | PMS-IRBESARTAN-HCTZ | 300 MG; 12.5 MG | TABLET | PHARMASCIENCE INC | MARKETED |
| 02328534 | PMS-IRBESARTAN-HCTZ | 300 MG; 25 MG | TABLET | PHARMASCIENCE INC | MARKETED |
| 02365162 | PRO-IRBESARTAN-HCTZ | 12.5 MG; 150 MG | TABLET | PRO DOC LIMITEE | MARKETED |
| 02365189 | PRO-IRBESARTAN-HCTZ | 25 MG; 300 MG | TABLET | PRO DOC LIMITEE | MARKETED |
| 02365170 | PRO-IRBESARTAN-HCTZ | 300 MG; 12.5 MG | TABLET | PRO DOC LIMITEE | MARKETED |
| 02337428 | SANDOZ IRBESARTAN HCT | 12.5 MG; 150 MG | TABLET | SANDOZ CANADA INCORPORATED | MARKETED |
| 02337436 | SANDOZ IRBESARTAN HCT | 12.5 MG; 300 MG | TABLET | SANDOZ CANADA INCORPORATED | MARKETED |
| 02337444 | SANDOZ IRBESARTAN HCT | 25 MG; 300 MG | TABLET | SANDOZ CANADA INCORPORATED | MARKETED |
| 02330512 | TEVA-IRBESARTAN HCTZ | 150 MG; 12.5 MG | TABLET | TEVA CANADA LIMITED | MARKETED |
| 02330539 | TEVA-IRBESARTAN HCTZ | 25 MG; 300 MG | TABLET | TEVA CANADA LIMITED | MARKETED |
| 02330520 | TEVA-IRBESARTAN HCTZ | 300 MG; 12.5 MG | TABLET | TEVA CANADA LIMITED | MARKETED |